Sign in
4

Changes in Ownership

PROVECTUS BIOPHARMACEUTICALS, INC. Filed Acc 0001493152-22-032433

Options or other derivatives

  • Director acquired 0 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Pershing Edward Director 2022-11-08 Grant or award · 8% Unsecured Convertible Promissory Note due 2023 +0 $100,000.00 $0 D: show line 1 in the form
Loading xslF345X03/ownership.xml…